[go: up one dir, main page]

PE20090496A1 - Derivados de espirociclopentano como antagonistas del receptor h1 - Google Patents

Derivados de espirociclopentano como antagonistas del receptor h1

Info

Publication number
PE20090496A1
PE20090496A1 PE2008001269A PE2008001269A PE20090496A1 PE 20090496 A1 PE20090496 A1 PE 20090496A1 PE 2008001269 A PE2008001269 A PE 2008001269A PE 2008001269 A PE2008001269 A PE 2008001269A PE 20090496 A1 PE20090496 A1 PE 20090496A1
Authority
PE
Peru
Prior art keywords
spirocyclopentane
dibenzo
alkyl
antagonists
receptor
Prior art date
Application number
PE2008001269A
Other languages
English (en)
Inventor
Emiliano Castiglioni
Fabio Romano Di
Massimo Gianotti
Milan Mesic
Francesca Pavone
Slavko Rast
Luigi Piero Stasi
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0714712A external-priority patent/GB0714712D0/en
Priority claimed from GB0723318A external-priority patent/GB0723318D0/en
Priority claimed from GB0806289A external-priority patent/GB0806289D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of PE20090496A1 publication Critical patent/PE20090496A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00Compounds containing amino groups bound to a carbon skeleton
    • C07C211/33Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C07C211/34Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of a saturated carbon skeleton
    • C07C211/38Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of a saturated carbon skeleton containing condensed ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00Systems containing at least three condensed rings
    • C07C2603/93Spiro compounds
    • C07C2603/94Spiro compounds containing "free" spiro atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
  • Indole Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

REFERIDA A COMPUESTOS DERIVADOS DE ESPIROCICLOPENTANO DE FORMULA (I) DONDE X ES CH2, C=O, O O S; R1 ES ALQUILO(C1-C4), ALCOXI(C1-C4) O HALOGENO; R2 ES ALQUILO(C1-C4), ALCOXI(C1-C4) O HALOGENO; R3 Y R4 SON CADA UNO H, ALQUILO(C1-C6), CARBOXIALQUILO(C1-C6), ENTRE OTROS; R5 ES H U OXO; n ES DE 0 A 2; m ES DE 0 A 2. SON COMPUESTOS PREFERIDOS: SAL FORMIATO DE N-(5',11'-DIHIDROESPIRO[CICLOPENTANO-1,10'-DIBENZO[a,d]CICLOHEPTEN]-3-IL)-b-ALANINA, ACIDO (-) 1-(5',11'-DIHIDROESPIRO[CICLOPENTANO-1,10'-DIBENZO[a,d]CICLOHEPTEN]-3-IL)-4-PIPERIDINACARBOXILICO, ACIDO 1-(2'-FLUORO-11'-OXO-11'H-ESPIRO[CICLOPENTANO-1,10'-DIBENZO[b,f]TIEPIN]-3-IL)-4-PIPERIDINACARBOXILICO, ENTRE OTROS. SE REFIERE TAMBIEN A UNA COMPOSICION FARMACEUTICA. DICHOS COMPUESTOS SON ANTAGONISTAS DEL RECEPTOR H1 SIENDO UTILES EN EL TRATAMIENTO DE TRASTORNOS DEL SUENO
PE2008001269A 2007-07-27 2008-07-25 Derivados de espirociclopentano como antagonistas del receptor h1 PE20090496A1 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0714712A GB0714712D0 (en) 2007-07-27 2007-07-27 Novel compounds
GB0723318A GB0723318D0 (en) 2007-11-28 2007-11-28 Novel compounds
GB0806289A GB0806289D0 (en) 2008-04-07 2008-04-07 Novel compounds

Publications (1)

Publication Number Publication Date
PE20090496A1 true PE20090496A1 (es) 2009-05-30

Family

ID=39956342

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2008001269A PE20090496A1 (es) 2007-07-27 2008-07-25 Derivados de espirociclopentano como antagonistas del receptor h1

Country Status (8)

Country Link
US (1) US20100190764A1 (es)
EP (1) EP2178823A1 (es)
JP (1) JP2010534704A (es)
AR (1) AR067689A1 (es)
CL (1) CL2008002195A1 (es)
PE (1) PE20090496A1 (es)
TW (1) TW200914010A (es)
WO (1) WO2009016084A1 (es)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4198418A (en) * 1979-01-10 1980-04-15 American Hoechst Corporation Spiro[dibenz(b,f)oxepin-piperidine]s
US4198420A (en) * 1979-01-10 1980-04-15 American Hoechst Corporation Spiro[dibenz(b,f)thiepin-piperidine]s
US6806283B2 (en) * 2002-05-06 2004-10-19 Virginia Commonwealth University Selective serotonin receptor antagonists and therapeutic applications thereof

Also Published As

Publication number Publication date
AR067689A1 (es) 2009-10-21
CL2008002195A1 (es) 2009-01-30
JP2010534704A (ja) 2010-11-11
EP2178823A1 (en) 2010-04-28
TW200914010A (en) 2009-04-01
US20100190764A1 (en) 2010-07-29
WO2009016084A1 (en) 2009-02-05

Similar Documents

Publication Publication Date Title
PE20080890A1 (es) DERIVADOS DE IMIDAZOLONA E IMIDAZOLIDINONA COMO INHIBIDORES DE LA 11b-HSD1 PARA LA DIABETES
PE20091173A1 (es) Derivados de heteroarilo como antagonistas de receptor de orexina
PE20110703A1 (es) Acidos naftilaceticos
PE20081800A1 (es) NUEVOS DERIVADOS DE 3-([1,2,4]TRIAZOLO[4,3-a]PIRIDIN-7-IL)BENZAMIDA
PE20091466A1 (es) Derivados de 4,5-dihidro-oxazol-2-il-amina
DE602008005771D1 (de) Disubstituierte alkyl-8-azabicycloä3.2.1üoktan-verbindungen als mu-opioid-rezeptorantagonisten
PE20080205A1 (es) DERIVADOS DE PIRAZOLOPIRIDINAS SUSTITUIDAS COMO INHIBIDORES DE LA TIROSIN QUINASA Tie2
PE20121500A1 (es) 2-amino-5,5-difluor-5,6-dihidro-4h-oxazinas como inhibidores de bace 1 y/o bace 2
PE20091734A1 (es) Compuestos de 2-imino-3-metilpirrolopirimidinona fenilo-sustituida como inhibidores de bace-1, composiciones y su uso
PE20120062A1 (es) Derivados de 1-bencil-2-amino-tetralina como inhibidores del transportador de glicina glyt1
PE20130279A1 (es) Compuestos heteroarilo nitrogenados
PE20091884A1 (es) Antagonistas de cgrp seleccionados, procedimiento para su preparacion, asi como su uso como medicamento
PE20071152A1 (es) Compuestos derivados de azabiciclo[3.1.0]hex como moduladores de receptores de dopamina d3
PE20081579A1 (es) Derivados de benzamida como agonistas del receptor
PE20090622A1 (es) Nuevos derivados de bencimidazol sustituido
PE20080056A1 (es) Derivados de cromencarboxamida como antagonistas del receptor s1p1
PE20081665A1 (es) Antagonistas del receptor de dopamina 2 de rapida disociacion
TW200800981A (en) 8-azabicyclo[3.2.1]octane compounds as MU opioid receptor antagonists
PE20120593A1 (es) Derivados fusionados de pirimidin-4-ona como antagonistas del receptor de angiotensina ii y como agonistas del receptor ppar gamma
MX2009004780A (es) Derivados de quiniclidina de acido (hetero) arilcicloheptano carboxilico como antagonistas del receptor muscarinico.
PE20081876A1 (es) Aminoamidas como antagonistas de orexina
MX2010002171A (es) Compuestos 8-azabiciclo[3.2.1] octil-2 hidroxibenzamida como antagonistas de los receptores opioides mu.
PE20120810A1 (es) Compuestos derivados de 5-ciano-2-(feniltio)bencensulfonamida como antagonistas de ccr3
DE602008003221D1 (de) Prolinamidderivate als nk3-antagonisten
PE20110710A1 (es) Acidos naftilaceticos

Legal Events

Date Code Title Description
FD Application declared void or lapsed